Favor peptide γ-EC and γ-EV inhibited IκBα and JNK activation and expressions of IL-1β, IL-6, IL-17, INF-γ, and TNF-α and increased IL-10 expression in IBD mice [47]. This evidence concerns the gene IL1B and inflammatory bowel disease.